JUN 16, 2017 6:07 AM PDT

Vitamin C & Antibiotics: A Potent Duo Against Cancer?

WRITTEN BY: Xuan Pham

Over the years, vitamin C has become synonymous with health, vigor, and vitality. Now the compound, in combination with an antibiotic, has been shown to be effective at killing cancer stem cells. The discovery shines a new light on vitamin C and its cancer-killing potential.

Image credit: Pixabay.com

Vitamin C has a long record with the medical community. In 1753, the compound was shown to ward off scurvy – a condition that was common among sailors at the time. Since then, vitamin C was purported to be effective against viruses like the common cold and the flu. Moreover, this compound has also been explored as an anticancer agent for several types of cancer, including colon cancer and leukemia.

But targeting cancer stem cells with vitamin C has never been attempted before. Similar to healthy stem cells, cancer stem cells  have the capacity to self-renew and differentiate into many other cell types. In the case of cancer stem cells, however, the result could be new tumor formation, metastasis, and drug resistance. "Therefore, new therapeutic strategies are necessary to identify and eradicate CSCs," the authors wrote in their study, published in the journal Oncotarget.

In the current study, the researchers are expanding on one of their previous findings - that vitamin C alone was able to kill cancer stem cells. Now, they’re testing whether this cancer-killing potential can be augmented with the addition of doxycycline, a common antibiotic.

Indeed, the team found that the vitamin C plus antibiotic combination was 100 times more effective at killing cancer stem cells than 2-DG, a drug under clinical trial to treat cancer. This is about 10 times more potent than treating the cancer cells with vitamin C alone.

The researchers hypothesize that the antibiotic stymied the cancer’s ability to switch fuels for energy. That is, without “metabolic flexibility,” as induced by the doxycycline, the cancer cells had to rely solely on glucose for survival. Then, they hypothesize that vitamin C acted as a “second punch,” and removed the source of glucose, which starved the cancer cells.

"In this scenario, vitamin C behaves as an inhibitor of glycolysis, which fuels energy production in mitochondria, the 'powerhouse' of the cell," said Dr. Federica Sotgia, a study co-author.

"This is further evidence that vitamin C and other non-toxic compounds may have a role to play in the fight against cancer," said Dr. Lisanti. "Our results indicate it is a promising agent for clinical trials, and as an add-on to more conventional therapies, to prevent tumor recurrence, further disease progression, and metastasis."

Additional source: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 15, 2020
Cancer
Soy helps post-op treatment of bone cancer
SEP 15, 2020
Soy helps post-op treatment of bone cancer
New research published in the journal Acta Biomaterialia highlights the post-operative benefits of soy in treatment ...
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
NOV 07, 2020
Cancer
Newly identified biomarker sheds light on antiangiogenic drug responses
NOV 07, 2020
Newly identified biomarker sheds light on antiangiogenic drug responses
A study published last week in the journal EMBO Molecular Medicine provides insight into the molecular mechanisms t ...
Loading Comments...